Catalyst Wire Dossier Catalyst Wire Dossier

Talineuren (TLN)

Talineuren · InnoMedica Schweiz AG
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Talineuren (TLN), covering 2024-05-29 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients [Phase 1]

See pricing